Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Breo ellipta 200 25?

See the DrugPatentWatch profile for Breo

What is Breo Ellipta 200/25, exactly?

Breo Ellipta 200/25 is a prescription inhaler that combines two medicines:
- fluticasone furoate (an inhaled corticosteroid, or ICS) at 200 mcg
- vilanterol (a long-acting beta2-agonist, or LABA) at 25 mcg

It is used for long-term control of airflow problems (typically COPD and sometimes asthma, depending on the product labeling and your prescriber’s instructions). The “200/25” refers to the strength of the two active ingredients per inhalation.

What condition is Breo Ellipta 200/25 used for?

The main use of Breo Ellipta products is maintenance treatment (daily long-term therapy), not quick relief of sudden breathing problems. Patients generally use it to reduce symptoms and the risk of flare-ups over time.

If you meant a specific approval/indication (asthma vs COPD) or want to confirm it for your country, tell me your country and whether you’re asking for asthma or COPD.

How do you take Breo Ellipta 200/25?

Breo Ellipta is typically dosed once daily. You usually:
- inhale the dose through the mouth (no spacer needed unless your clinician advises it)
- rinse your mouth and spit after use to help reduce mouth/throat side effects from the steroid
- use a separate, faster “rescue” inhaler if prescribed for sudden symptoms

Your exact instructions may vary by your prescription and local labeling.

What side effects do people commonly ask about?

Common concerns with Breo Ellipta (because it contains a steroid plus a LABA) include:
- hoarseness or throat irritation
- oral thrush (yeast infection in the mouth), which rinsing helps reduce
- cough
- headache
- nervousness or tremor (more associated with beta2-agonists)

Because it’s a steroid, clinicians also watch for longer-term effects in some patients, especially at higher doses.

What risks should patients know before using it?

Key safety points people usually want to understand:
- LABA medicines can increase risk in asthma when used without the right controller regimen; that’s one reason the ICS/LABA combination matters.
- It does not treat sudden attacks; you still need a rescue inhaler if you’re prescribed one.
- If symptoms worsen after starting, you should contact your clinician rather than just increasing doses on your own.

What’s the difference between Breo Ellipta 100/25 and 200/25?

The difference is the steroid strength:
- 100/25 has 100 mcg fluticasone furoate
- 200/25 has 200 mcg fluticasone furoate

Higher doses usually mean more steroid exposure, which can be appropriate for people whose control isn’t adequate at the lower strength.

Is “Breo 200 25” a patent or pricing question?

If you’re asking about patents, generics, or whether a cheaper version might be available, tell me your country (and whether you mean Breo Ellipta inhaler or fluticasone/vilanterol generics). I can then point you to relevant coverage using DrugPatentWatch.com, which tracks patent and exclusivity information for drugs.

If you reply with what you’re trying to figure out (how to use it, side effects, asthma vs COPD, or cost/patent), I’ll tailor the answer.



Other Questions About Breo :

breo ellipta coupons breo ellipta 200/25 coupon breo 100/25 breo ellipta patent expiration 2030 breo ellipta 100/25 Is breo ellipta a once daily or twice daily inhaler? Is Breo Ellipta a once-daily or twice-daily inhaler?